B Cell Malignancies: Clinical Trials

5 trials for B Cell Malignancies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 not yet recruiting. 5 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Not yet recruiting 5
Phase 23Not yet recruiting 3

Follow B Cell Malignancies: new trials by email Literature Review of B Cell Malignancies trials Research Report on B Cell Malignancies

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CD19/70 Bi-specific CAR-T Cell Therapy
bi-4SCAR CD19/70 T cells - B Cell Malignancies
Phase 1 / Phase 2Not yet recruitingShenzhen Geno-Immune Medical Institute302027-06-012026-08-26
CD19/22 Bi-specific CAR-T Cell Therapy
bi-4SCAR CD19/22 T cells - B Cell Malignancies
Phase 1 / Phase 2Not yet recruitingShenzhen Geno-Immune Medical Institute602027-06-012026-08-26
4SCAR19U T Cells Targeting B Cell Malignancies
Universal CD19-specific CAR gene-engineered T cells - B Cell Malignancies
Phase 1Not yet recruitingShenzhen Geno-Immune Medical Institute302026-12-312026-09-01
A Phase 1/2 Study of T-cell Expressing a Novel CD19 Chimeric-Antigen Receptor (SHB-02-CD19) in Patients With CD19-expressing B-cell Malignancies
SHB-02-CD19 (anti CD19 CAR-T cells) - B Cell Malignancies, Acute Lymphobkastic Leukemia
Phase 1 / Phase 2Not yet recruitingSheba Medical Center502026-06-012026-03-31
Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial)
Experimental Intervention - B Cell Malignancies, B-cell Leukemia
Phase 1Not yet recruitingUniversity Hospital, Basel, Switzerland122026-06-012025-12-24

Narrower conditions

Cytokine Release Syndrome (1)  ·  Leukemia, B-Cell (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Recurrence (1)

Broader conditions

Disease Attributes (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Inflammation (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Sponsors

Shenzhen Geno-Immune Medical Institute (3)  ·  Sheba Medical Center (1)  ·  University Hospital, Basel, Switzerland (1)

Countries

China (3)  ·  Israel (1)  ·  Switzerland (1)

Top investigators

Andreas Holbro, Prof. Dr. (1)

NIH funding

2025 (1)